Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of advanced therapies.

Scale-up involves increasing pump sizes, reactor volumes, and flow rates—but the process control logic and system ...

Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacturing — a key step in bringing ...

Using patent intelligence data from the FounderNest platform, alongside funding, partnership, and deployment signals across ...

Charles R. Goulding and Andressa Bonafe highlight the shift from clinical pilot programs to everyday pharmacy practice, where ...

Subsequent phase involves completion of chemistry, manufacturing, and controls (CMC) testing for data to support FDA submission Company expects to commence bioavailability study in April 2025 Aspire ...

In the world of drug discovery and clinical trials, drug formulation can make or break a product’s success, yet its role often goes underappreciated, says Christine Allen, cofounder and CEO of ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent pending drug delivery ...